Genesis Molecular AI
This role serves as a critical bridge between long-term AI research and experimental drug discovery programs at Genesis Molecular AI. The position involves building, evaluating, and deploying state-of-the-art generative foundation models to solve real-world challenges in small molecule drug discovery. The successful candidate will collaborate with multidisciplinary teams to validate predictions, curate datasets, and guide the discovery of new medicines.
Genesis Molecular AI is a biotechnology company delivering the industry’s most advanced molecular AI platform to unlock tough protein targets and accelerate drug discovery at scale. Its platform combines AI-driven analytics with molecular understanding to identify viable targets and design candidate medicines more efficiently. The solution is tailored for biotech and pharmaceutical teams seeking scalable, data-driven discovery workflows that shorten preclinical timelines. Genesis positions itself as a leader in AI-enabled drug discovery, helping researchers move faster from target to medicine.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Genesis Molecular AI.
Genesis Molecular AI didn’t post a salary, so this is our estimate from similar listings.
10% below the average for this role
Computational Chemistry Scientist
Roche
Small Molecule Computational Scientist
Boltz
Cheminformatics/Computational Chemistry Scientist
Eli Lilly and Company
Post-Doctoral Fellow
The Wistar Institute
Senior Scientist I / Senior Scientist II
Antares Therapeutics
Senior Director, AIRx Computational Chemistry
Takeda Pharmaceutical Company Limited